These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5131086)

  • 61. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia.
    Rocić B; Breyer D; Granić M; Milutinović S
    Horm Metab Res; 1991 Oct; 23(10):490-4. PubMed ID: 1761280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemical speciation of arsenic in serum of uraemic patients.
    Zhang X; Cornelis R; Mees L; Vanholder R; Lameire N
    Analyst; 1998 Jan; 123(1):13-7. PubMed ID: 9581013
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones.
    D'Hooge R; De Deyn PP; Van de Vijver G; Antoons G; Raes A; Van Bogaert PP
    Neurosci Lett; 1999 Apr; 265(2):83-6. PubMed ID: 10327174
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nondialyzable toxic factor in uraemic blood effectively removed by the activated charcoal.
    Yatzidis H; Psimenos G; Mayopoulou-Symvoulidis D
    Experientia; 1969 Nov; 25(11):1144-5. PubMed ID: 5357814
    [No Abstract]   [Full Text] [Related]  

  • 65. Fast atom bombardment mass spectrometric determination of the molecular weight range of uremic compounds that displace phenytoin from protein binding: absence of midmolecular uremic toxins.
    Dasgupta A; Malik S
    Am J Nephrol; 1994; 14(3):162-8. PubMed ID: 7977474
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Production of methylguanidine in dogs with acute and chronic renal failure.
    Brooks DP; Rhodes GR; Woodward P; Boppana VK; Mallon FM; Griffin HE; Kinter LB
    Clin Sci (Lond); 1989 Dec; 77(6):637-41. PubMed ID: 2605868
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of arginine or creatinine administration on the urinary excretion of methylguanidine.
    Orita Y; Tsubakihara Y; Ando A; Nakata K; Takamitsu Y; Fukuhara Y; Abe H
    Nephron; 1978; 22(4-6):328-36. PubMed ID: 740094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of plasma neurotoxin concentration in uraemic polyneuropathic patients.
    Man NK; Cueille G; Zingraff J; Drueke T; Jungers P; Sausse A; Boudet J; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1978; 15():164-70. PubMed ID: 216989
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinico-biochemical aspects of guanidine compounds in uraemic toxicity.
    Kishore BK; Kállay Z; Tulkens PM
    Int Urol Nephrol; 1989; 21(2):223-32. PubMed ID: 2663758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    Dasgupta A; Jacques M
    Am J Clin Pathol; 1994 Mar; 101(3):349-53. PubMed ID: 8135194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Removal of guanidinosuccinic acid by hemodialysis.
    Perez G; Abraira C; Rey A; Horn M
    Nephron; 1977; 19(4):214-9. PubMed ID: 917168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of rhubarb tannins on uremic toxins.
    Yokozawa T; Fujioka K; Oura H; Nonaka G; Nishioka I
    Nephron; 1991; 58(2):155-60. PubMed ID: 1865970
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.
    Horowitz HI; Stein IM; Cohen BD; White JG
    Am J Med; 1970 Sep; 49(3):336-45. PubMed ID: 5455565
    [No Abstract]   [Full Text] [Related]  

  • 74. Carbamylated haemoglobin in normal, diabetic and uraemic patients.
    Kwan JT; Carr EC; Barron JL; Bending MR
    Ann Clin Biochem; 1992 Mar; 29 ( Pt 2)():206-9. PubMed ID: 1626926
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extraction of uraemic toxins with activated carbon restores the functional properties of albumin.
    Sarnatskaya VV; Lindup WE; Ivanov AI; Yushko LA; Tjia J; Maslenny VN; Gurina NM; Nikolaev VG
    Nephron Physiol; 2003; 95(1):p10-8. PubMed ID: 14520007
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Simultaneous determination of serum cations, anions and uremic toxins by ion chromatography using an immobilized enzyme.
    Shintani H; Ube S
    J Chromatogr; 1985 Nov; 344():145-56. PubMed ID: 4086536
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    De Deyn PP; Macdonald RL
    Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Creatinine: a precursor of methylguanidine.
    Perez G; Faluotico R
    Experientia; 1973 Dec; 29(12):1473-4. PubMed ID: 4772033
    [No Abstract]   [Full Text] [Related]  

  • 79. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of active oxygen on methylguanidine synthesis in isolated rat hepatocytes.
    Aoyagi K; Nagase S; Narita M; Tojo S
    Kidney Int Suppl; 1987 Oct; 22():S229-33. PubMed ID: 3480990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.